Literature DB >> 16115629

Overexpression of proadrenomedullin N-terminal 20 peptide blunts blood pressure rise and attenuates myocardial hypertrophy and fibrosis in hypertensive rats.

Yuan-Ning Cao1, Kenji Kuwasako, Johji Kato, Kensaku Nishihira, Yujiro Asada, Tanenao Eto, Kazuo Kitamura.   

Abstract

We developed a transgenic (Tg) rat model that overexpresses human proadrenomedullin N-terminal 20 peptide (PAMP) only and then compared the effects of unilateral nephrectomy followed by a high salt diet for five weeks in Tg and wild-type rats. We found that systolic blood pressure was significantly lower in Tg UNX rats and cardiac hypertrophy and myocardial fibrosis was also attenuated in Tg rats. Evaluation of gene expression showed suppression of cardiac local renin-angiotensin system (RAS) in Tg rat. These results suggest that in addition to reducing blood pressure, PAMP suppresses cardiac hypertrophy through negative regulation of the local cardiac RAS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16115629     DOI: 10.1016/j.febslet.2005.08.007

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  1 in total

1.  Genetic loss of proadrenomedullin N-terminal 20 peptide (PAMP) in mice is compatible with survival.

Authors:  Brooke C Matson; Manyu Li; Claire E Trincot; Elizabeth S Blakeney; Stephanie L Pierce; Kathleen M Caron
Journal:  Peptides       Date:  2018-12-08       Impact factor: 3.750

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.